A double-blind multicenter, randomized, placebo-controlled single dose study to evaluate the safety and efficacy of Trexima in the acute treatment of migraine headaches.
Latest Information Update: 20 Aug 2023
At a glance
- Drugs Naproxen sodium/sumatriptan (Primary) ; Naproxen sodium; Sumatriptan
- Indications Migraine
- Focus Registrational; Therapeutic Use
- Sponsors POZEN
- 13 Sep 2009 Results from a pooled analysis (CTP profiles 700021536 and 700021530) were reported at the 14th International Headache Congress & the 51st Annual Scientific Meeting of the American Headache Society (Joint meeting).
- 10 Mar 2007 New trial record.